GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study

Stopped early

Conditions studied: Breast Cancer

In brief

This post-approval study is designed to determine the performance of the FDA-approved GeneSearch™ BLN Assay when compared to the site's standard of care permanent section histological evaluation, and when compared to more extensive histological evaluation when the assay is being used by clinicians to make surgical decisions on complete axillary dissections (ALND).

Key facts

Study ID
NCT00595296
Run by
Janssen Diagnostics, LLC
People needed
461
Starts
2007-12-01
Expected to finish
2009-12-01
Last updated by the study team
2016-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.